In 2011, Biofarm posted a net profit of RON14.22 million.
The company reported sales of RON104.97 million in 2012, versus RON93.44 million in the previous year.
Overall revenues rose 12.7% to RON111.3 million, while total costs advanced 7.3% to RON87.7 million, Biofarm said in its preliminary financial report.
Biofarm has a share capital of RON109.4 million split into 1.09 billion shares with a face value of RON0.1.
Romanian regional investment funds SIF Oltenia (SIF5.RO), SIF Banat Crisana (SIF1.RO) and SIF Moldova (SIF2.RO) own together around 58% of Biofarm’s shares.
On the Bucharest bourse Friday, Biofarm closed flat at RON0.232 a share, amid a rising market. (EUR1=RON4.3885)